Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yellin

Showing results (571-580 of 625) with videos related to

Pageof 63
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4Peter Attia, Giao Q Phan, Ajay V Maker, et al.
Frontiers in Immunology|April 1, 2025
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal modelsIrene González-Domínguez, Adam Abdeljawad, Tsoi Ying Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast CancerDenise A Yardley, Robert Weaver, Michelle E Melisko, et al.
Plos Pathogens|January 7, 2026
Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donorsJianyu Lai, Hamed Sobhani, Kristen K Coleman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Evaluating Modes of Influenza Transmission (EMIT-2): Challenges of a Controlled Human Influenza Virus Infection Transmission Trial (CHIVITT)Jianyu Lai, Hamed Sobhani, Kristen K Coleman, et al.
European Journal of Pain (London, England)|October 16, 2020
Medical cannabis treatment for chronic pain: Outcomes and prediction of responseJoshua Aviram, Dorit Pud, Tamar Gershoni, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Revitalizing systemic immune responses in advanced NSCLC using FLT3L and SBRTDivij Mathew, Nitin Ohri, Shin Foong Ngiow, et al.
British Journal of Haematology|May 29, 2010
Monoclonal gammopathy of undetermined significance: a consensus statementJames R Berenson, Kenneth C Anderson, Robert A Audell, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Frontiers in Immunology|March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapyJair Bar, Raya Leibowitz, Niels Reinmuth, et al.
Pageof 63

Showing results (571-580 of 625) with videos related to

Sort By:
Pageof 63
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4Peter Attia, Giao Q Phan, Ajay V Maker, et al.
Frontiers in Immunology|April 1, 2025
Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal modelsIrene González-Domínguez, Adam Abdeljawad, Tsoi Ying Lai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast CancerDenise A Yardley, Robert Weaver, Michelle E Melisko, et al.
Plos Pathogens|January 7, 2026
Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donorsJianyu Lai, Hamed Sobhani, Kristen K Coleman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
Evaluating Modes of Influenza Transmission (EMIT-2): Challenges of a Controlled Human Influenza Virus Infection Transmission Trial (CHIVITT)Jianyu Lai, Hamed Sobhani, Kristen K Coleman, et al.
European Journal of Pain (London, England)|October 16, 2020
Medical cannabis treatment for chronic pain: Outcomes and prediction of responseJoshua Aviram, Dorit Pud, Tamar Gershoni, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Revitalizing systemic immune responses in advanced NSCLC using FLT3L and SBRTDivij Mathew, Nitin Ohri, Shin Foong Ngiow, et al.
British Journal of Haematology|May 29, 2010
Monoclonal gammopathy of undetermined significance: a consensus statementJames R Berenson, Kenneth C Anderson, Robert A Audell, et al.
The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.
Frontiers in Immunology|March 15, 2024
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapyJair Bar, Raya Leibowitz, Niels Reinmuth, et al.
Pageof 63